BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34000577)

  • 1. Curcumin reverses doxorubicin resistance in colon cancer cells at the metabolic level.
    Zhang N; Gao M; Wang Z; Zhang J; Cui W; Li J; Zhu X; Zhang H; Yang DH; Xu X
    J Pharm Biomed Anal; 2021 Jul; 201():114129. PubMed ID: 34000577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quercetin overcomes colon cancer cells resistance to chemotherapy by inhibiting solute carrier family 1, member 5 transporter.
    Zhou Y; Zhang J; Wang K; Han W; Wang X; Gao M; Wang Z; Sun Y; Yan H; Zhang H; Xu X; Yang DH
    Eur J Pharmacol; 2020 Aug; 881():173185. PubMed ID: 32422185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect and mechanistic study of encequidar on reversing the resistance of SW620/AD300 cells to doxorubicin.
    Zhang H; Bian S; Xu Z; Gao M; Wang H; Zhang J; Zhang M; Ke Y; Wang W; Chen ZS; Xu H
    Biochem Pharmacol; 2022 Nov; 205():115258. PubMed ID: 36179932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma differentiation associated gene-7/interleukin-24 reverses multidrug resistance in human colorectal cancer cells.
    Emdad L; Lebedeva IV; Su ZZ; Sarkar D; Dent P; Curiel DT; Fisher PB
    Mol Cancer Ther; 2007 Nov; 6(11):2985-94. PubMed ID: 18025283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
    Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomics analysis of multidrug resistance in colorectal cancer cell and multidrug resistance reversal effect of verapamil.
    Wang X; Wang Z; Wang K; Gao M; Zhang H; Xu X
    Biomed Chromatogr; 2021 Feb; 35(2):e4976. PubMed ID: 32852057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tea nanoparticle, a safe and biocompatible nanocarrier, greatly potentiates the anticancer activity of doxorubicin.
    Wang YJ; Huang Y; Anreddy N; Zhang GN; Zhang YK; Xie M; Lin D; Yang DH; Zhang M; Chen ZS
    Oncotarget; 2016 Feb; 7(5):5877-91. PubMed ID: 26716507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistically Improved Anti-tumor Efficacy by Co-delivery Doxorubicin and Curcumin Polymeric Micelles.
    Wang J; Ma W; Tu P
    Macromol Biosci; 2015 Sep; 15(9):1252-61. PubMed ID: 25981672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
    Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M
    Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphiphilic Copolymeric Micelles for Doxorubicin and Curcumin Co-Delivery to Reverse Multidrug Resistance in Breast Cancer.
    Lv L; Qiu K; Yu X; Chen C; Qin F; Shi Y; Ou J; Zhang T; Zhu H; Wu J; Liu C; Li G
    J Biomed Nanotechnol; 2016 May; 12(5):973-85. PubMed ID: 27305819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of multidrug resistance in breast cancer cells by a combination of ursolic acid with doxorubicin.
    Zong L; Cheng G; Liu S; Pi Z; Liu Z; Song F
    J Pharm Biomed Anal; 2019 Feb; 165():268-275. PubMed ID: 30572191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zwitterionic Polymer Micelles with Dual Conjugation of Doxorubicin and Curcumin: Synergistically Enhanced Efficacy against Multidrug-Resistant Tumor Cells.
    Zhao G; Sun Y; Dong X
    Langmuir; 2020 Mar; 36(9):2383-2395. PubMed ID: 32036662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles.
    Duan J; Mansour HM; Zhang Y; Deng X; Chen Y; Wang J; Pan Y; Zhao J
    Int J Pharm; 2012 Apr; 426(1-2):193-201. PubMed ID: 22274587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin Reverses 5-Fluorouracil Resistance by Promoting Human Colon Cancer HCT-8/5-FU Cell Apoptosis and Down-regulating Heat Shock Protein 27 and P-Glycoprotein.
    He WT; Zhu YH; Zhang T; Abulimiti P; Zeng FY; Zhang LP; Luo LJ; Xie XM; Zhang HL
    Chin J Integr Med; 2019 Jun; 25(6):416-424. PubMed ID: 30484020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
    Ramachandran C; Wellham LL
    Anticancer Res; 2003; 23(3B):2681-90. PubMed ID: 12894558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of P-glycoprotein (P-gp) mediated multidrug resistance in colon cancer cells by cryptotanshinone and dihydrotanshinone of Salvia miltiorrhiza.
    Hu T; To KK; Wang L; Zhang L; Lu L; Shen J; Chan RL; Li M; Yeung JH; Cho CH
    Phytomedicine; 2014 Sep; 21(11):1264-72. PubMed ID: 25172788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a novel biocompatible magnetic nanomedicine based on beta-cyclodextrin, loaded doxorubicin-curcumin for overcoming chemoresistance in breast cancer.
    Rastegar R; Akbari Javar H; Khoobi M; Dehghan Kelishadi P; Hossein Yousefi G; Doosti M; Hossien Ghahremani M; Shariftabrizi A; Imanparast F; Gholibeglu E; Gholami M
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):207-216. PubMed ID: 29688063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy.
    Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O
    Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX; Yang XH
    Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNA-29a reverses P-glycoprotein-mediated drug resistance and inhibits proliferation via up-regulation of PTEN in colon cancer cells.
    Shi X; Valizadeh A; Mir SM; Asemi Z; Karimian A; Majidina M; Safa A; Yosefi B
    Eur J Pharmacol; 2020 Aug; 880():173138. PubMed ID: 32416187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.